No association of menopause and hormone replacement therapy with carotid artery intima-media thickness

Circulation

Volumn 94, Issue 8, 1996, Pages 1857-1863

  Nabulsi, Azmi A ^a,b,f   Folsom, Aaron R ^a   Szklo, Moyses ^c   White, Alice ^d   Higgins, Millicent ^e   Heiss, Gerardo ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b IL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Burroughs Wellcome Co   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f ABBOTT LABORATORIES   (United States)

Author keywords

atherosclerosis; hormones; menopause

Indexed keywords

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029800594     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.8.1857     Document Type: Article

References (46)

1. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993;88(pt 1): 1999-2009. Special Report.
2. Stampfer MJ, Colditz GA, Willett WC. Menopause and heart disease: a review. Ann N Y Acad Sci. 1990;592:193-203.
3. Ernster VL, Bush TL, Huggins GR, Hulka BS, Kelsey JL, Schottenfeld D. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med. 1988;17:201-223.
4. Lobo RA. Estrogen and cardiovascular disease. Ann N Y Acad Sci. 1990;592:286-294; discussion, 334-345.
5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016- 1037.
6. Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT, Weiss NS, Wagner EH, Prentice R, Furberg CD. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993;153:1421-1427.
7. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J. 1988;297:519-522.
8. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med. 1993;153:73-79.
9. Falkeborn M, Persson I, Adami HO, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naessen T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynecol. 1992;99:821-828.
10. Polak JF, O'Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, Gardin JM, Kittner SJ, Price TR, Savage PJ. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stoke and transient ischemic attack. Radiology. 1993;188:363-370.
11. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
12. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Grouse JR III. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation. 1990;82:1230- 1242.
13. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129- 687-702.
14. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiologic studies Am J Clin Nutr. 1982;36:936-942.
15. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2nd ed. Albany, NY: World Health Organization; 1982:178. WHO Monograph Series, No. 56.
16. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1:68-73.
17. Riley WA, Barnes RW, Bond MG, Evans G, Chambless LE, Heiss G. High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities Study (ARIC) cohort. J Neuroimaging. 1991;1:168-172.
18. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
19. Dempster AP, Laird NM, Rubin DB. Maximum likelihood estimation from incomplete data via the EM algorithm. J R Stat Soc. 1977; B39:1-38.
20. SAS Institute Inc. SAS/STAT User's Guide. Cary, NC: SAS Institute Inc;1,2:1985.
21. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle- aged French women. Arterioscler Thromb. 1991;11:966-972.
22. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. Br Med J. 1989;298:642-644.
23. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981;139:47-51.
24. Beard CM, Fuster V, Annegers JF. Reproductive history in women with coronary heart disease: a case-control study. Am J Epidemiol. 1981;120:108-114.
25. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383-390.
26. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
27. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coro- nary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-59.
28. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study. N Engl J Med. 1993;328:1069-1075.
29. Manolio TA, Furberg C, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 1993;88:2163-2171.
30. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Post- menopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988;115:954-963.
31. Sullivan JM, Zwaag VR, Lemp GF, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med. 1988;108:358-363.
32. McFarland KF, Boniface ME, Hornung CA, Earnhardt W, Humphries JO. Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J. 1989;117:1209-1214.
33. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol. 1992;69:176-178.
34. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
35. Falkeborn M, Persson I, Terent A, Adami HO, Lithel H, Bergström R. Hormone replacement therapy and the risk of stroke: follow-up of a population-based cohort in Sweden. Arch Intern Med. 1993;153:1201-1209.
36. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med. 1985;313:1038-1043.
37. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial in- farction in women. J Epidemiol Community Health. 1989;43: 173-178.
38. Qiu JM, Fan YC, Liu XL, Huang FG. Influences of estradiol and oral contraceptive I on experimental atherosclerosis. Angeiologie. 1989; 41:207-213.
39. Chang WC, Nakao J, Orimo M, Murota S. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta. 1980;620:472-482.
40. Sarrel PM, Lindsay D, Rosano GMC, Poole-Wilson PA. Angina and normal coronary arteries in women: gynecologic findings. Am J Obstet Gynecol. 1992;167:467-472.
41. Bergqvist A, Bergqvist D, Ferno M. Estrogen and progesterone receptors in vessel walls: biochemical and immunochemical assays. Acta Obstet Gynecol Scand. 1993;72:10-16.
42. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to trans- dermal oestradiol and time since menopause. Lancet. 1991;338: 839-842.
43. Niki E, Nakato M. Estrogens as antioxidants. Methods Enzymol. 1990;186:330-333.
44. Clarkson TB, Adams MR, Williams JK, Wagner JB. Effects of sex steroids on the monkey cardiovascular system: relation to changes in serum lipids and lipoproteins. In: Christiansen C, Overgaard K, eds. Osteoporosis. Copenhagen, Denmark: ITBA; 1990:1798-1805.
45. Haarbo J, Espensen PL, Slender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
46. Wagner JD, St Clair RW, Schwencke DC, Shively CA, Adams MR, Clarkson TB. Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys. Arterioscler Thromb. 1992;12:717-726.